CHARACTERIZATION OF THE INTERACTION OF THE MARINE CYANOBACTERIAL NATURAL PRODUCT CURACIN-A WITH THE COLCHICINE SITE OF TUBULIN AND INITIAL STRUCTURE-ACTIVITY STUDIES WITH ANALOGS
Av. Blokhin et al., CHARACTERIZATION OF THE INTERACTION OF THE MARINE CYANOBACTERIAL NATURAL PRODUCT CURACIN-A WITH THE COLCHICINE SITE OF TUBULIN AND INITIAL STRUCTURE-ACTIVITY STUDIES WITH ANALOGS, Molecular pharmacology, 48(3), 1995, pp. 523-531
Curacin A, the major lipid constituent of a strain of the marine cyano
bacterium Lyngbya majuscula obtained off the coast of Curacao, is a po
tent antimitotic agent that we have previously shown to inhibit microt
ubule assembly and colchicine binding to tubulin. In the present study
, we report that curacin A probably binds in the colchicine site becau
se it competitively inhibits the binding of [H-3]colchicine to tubulin
with an apparent K-i value bf 0.6 mu M and stimulates tubulin-depende
nt GTP hydrolysis, as do most other colchicine-site agents. The bindin
g of curacin A to tubulin resembled the binding reactions of combretas
tatin A-4 and podophyllotoxin in contrast to that of colchicine in tha
t it occurred as extensively on ice as at higher temperatures. However
, once bound, the dissociation rate of curacin A from tubulin is very
slow, more closely resembling that observed with colchicinoids (thioco
lchicine was the drug examined) than the faster dissociation that occu
rs with combretastatin A-4 and podophyllotoxin. Because the molecular
structure of curacin A is so different from that of previously describ
ed colchicine-site drugs (e.g., there is no aromatic moiety, and there
are only two conjugated double bonds in its linear hydrocarbon chain)
, we have been examining the activities of natural isomers and synthet
ic derivatives. So far, only modest enhancement or reduction of activi
ty has been observed with a variety of structural changes.